Methyl phenidyl acetate
Methyl phenidyl acetate Brand names, Methyl phenidyl acetate Analogs
- 4311/B Ciba
- Calocain
- Centedein
- Centedrin
- Centedrine
- Centredin
- Concerta
- Focalin
- Focalin XR
- Methylphen
- Meridil
- Metadate
- Metadate CD
- Metadate ER
- Methyl phenidyl acetate
- Methylin
- Methylin ER
- Methylofenidan
- Methylphenidan
- Methylphenidate HCl
- Methylphenidate hydrochloride
- Methylphenidatum [Inn-Latin]
- Methylphenidylacetate hydrochloride
- Methypatch
- Metilfenidat hydrochloride
- Metilfenidato [Inn-Spanish]
- Metilfenidato [Italian]
- Phenidylate
- Plimasine
- PMS-Methylphenidate
- Riphenidate
- Ritalin
- Ritalin hydrochloride
- Ritalin LA
- Ritalin SR
- Ritalin-SR
- Ritaline
- Ritcher Works
Methyl phenidyl acetate Brand Names Mixture
- No information avaliable
Methyl phenidyl acetate Chemical_Formula
C14H19NO2
Methyl phenidyl acetate RX_link
http://www.rxlist.com/cgi/generic/methphen.htm
Methyl phenidyl acetate fda sheet
Methyl phenidyl acetate msds (material safety sheet)
Methyl phenidyl acetate Synthesis Reference
M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)
Methyl phenidyl acetate Molecular Weight
233.306 g/mol
Methyl phenidyl acetate Melting Point
224-226oC
Methyl phenidyl acetate H2O Solubility
1255mg/L
Methyl phenidyl acetate State
Solid
Methyl phenidyl acetate LogP
3.192
Methyl phenidyl acetate Dosage Forms
Tablets; Tablets (sustained release)
Methyl phenidyl acetate Indication
For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Methyl phenidyl acetate Pharmacology
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.
Methyl phenidyl acetate Absorption
Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)
Methyl phenidyl acetate side effects and Toxicity
Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)
Methyl phenidyl acetate Patient Information
Methyl phenidyl acetate Organisms Affected
Humans and other mammals
